Stay up to date with the Medical Scientist Training Program (MSTP) by subscribing to our RSS news feed
June 15, 2015
APSA National Meeting Update
By Andrew Shubin, University of Rochester APSA Institutional Representative
The 11th Annual APSA National meeting was held in conjunction with the American Association of Physicians (AAP) and American Society of Clinical Investigation (ASCI) at the beautiful Fairfield Millennial Hotel on Lake Michigan, on April 24th-26th, 2015 in Chicago, IL. The meeting began with the annual APSA business meeting, where the 6 standing committees of APSA present their work to the institutional reps. Highlights of this meeting include push to increase APSA membership through APSA local chapters, fundraising of over $100,000 for APSA events, and the recent compilation of a survey of MD/PhD students to understand motivations and challenges for pursuing training which is currently in preparation in submission to be published. The rest of the meeting consisted of research talks given by premier physician scientists as well as numerous social networking events described below.
In addition to the invited APSA speakers, APSA members had complete access to all of the invited talks of the AAP and ASCI some highlights include:
Jeffrey Kline, MD
An emergency medicine trained physician scientist, Dr. Klein, talked about his lab’s work studying coagulation and fibrinolysis as well as his career as an academic emergency doctor with a strong research focus.
Douglas Lowy, MD
Acting director of the National Cancer Institute. Dr. Lowy played a major role in developing and implementing the HPV vaccine.
Jennifer Doudna, PhD
Dr. Doudna talked about her pioneering work in developing CRISPR-Cas9 method to modify DNA.
Frances Collins, MD, PhD
Dr. Collins was the recipient of the Kober Medal price. His early life, career, and major scientific contributions were highlighted by Dr. David Ginsburg. Dr. Collins graciously accepted the award, guitar in hand, by leading the audience in a sing-a-long.
Richard L Ehman MD
Dr. Ehman’s talk focused on how biomedical research, particularly NIH funded biomedical research, has one of the best return on investment, for any form of research in the US. Dr. Ehman also played a pivitoal role in developing MRI diagnostic technologies. Andy Cox also recruited him to be our next MSRS speaker!
APSA Welcome Reception
A social event for APSA members to mingle and meet those at other institutions held at the top of Hancock center, with arguably the best view of Chicago around.
Another great opportunity to meet students from other institutions. Our own Dr. Kerry O’Banion, was awarded the APSA founder’s award for his work advising and securing funding for APSA.
A dessert reception with a keynote given by the Nobel Prize winner Dr. Peter Agre on his career development and work discovering aquaporins.
An opportunity to meet with residency directors from residency programs with a strong research focus. Many of them being physician scientist training
In addition to this events there were also panels cover topics such as Women in Medicine and Science, Technological Innovation in Biomedical and Translation Research, and Post-Graduate Opportunities.
Overall, the 2015 APSA was an amazing experience, one I hope to attend next year as well. I would like to thank my fellow colleagues: Andy Cox, Aisha Siebert, Alison Gaylo, and Alex Hajduczok as well as Kerry O’Banion for representing Rochester well and making the conference a lot of fun. I hope everyone has the opportunity to attend this conference at least once!
June 14, 2015
Kerry O'Banion, interim chair of the Department of Neurobiology and Anatomy, and University President Emeritus Thomas Jackson will present
Patent Infringement: COX Fighting, from noon to 1 p.m. Wednesday, June 17, in Helen Wood Hall Auditorium. The event is part of the CTSI workshop series,
Good Advice: Case Studies in Clinical Research, Regulation, and the Law.
June 10, 2015
In Memoriam: Robert J. Arceci, MD, PhD
By Nina Schor, Chair, Department of Pediatrics, URMC
It is with great sadness that I report the death in a motorcycle accident of URSMD MSTP alumnus, Dr. Robert Arceci. Professionally, Bob was a truly outstanding clinician, researcher, and mentor in the area of pediatric hematology-oncology. He spent many years on the faculty at Johns Hopkins University, rising to the position of Chief of the Division of Pediatric Hematology-Oncology.
Almost two years ago, he moved to Phoenix Children’s Hospital to become Chief of Pediatric Hematology-Oncology there and to launch, as Director, The Ronald A. Matricaria Institute of Molecular Medicine. Personally, Bob was a gentle and caring person whose sense of humor, calm in the face of turmoil, and perspective made him a cherished friend and advisor to many. Our thoughts and prayers are with his wife, Jean, and sons, John-Carl and Andrew.
June 9, 2015
John J. Foxe, Ph.D., a nationally-regarded scientist in the field of neurobiology, has been named the research director of the DelMonte Neuromedicine Institute (DNI) and the Kilian J. and Caroline F. Schmitt Chair of the Department of Neurobiology and Anatomy at the University of Rochester School of Medicine and Dentistry.
The University of Rochester has long been home to some of the nation's most innovative and groundbreaking research in the field of neuroscience and neuromedicine,said Joel Seligman, president of the University of Rochester.
John's appointment signals our determination to make this field a centerpiece of our progress as a University and Medical Center.
I am honored to be taking the helm of the DNI at this incredibly exciting time in modern neuroscience research,said Foxe.
The University of Rochester is already world-renowned for its superb work in this field and we now have the opportunity to build an even stronger presence. Tens of millions of Americans suffer from a major mental illness each year, be it depression or anxiety, a major psychotic disorder, or Alzheimer's disease, stroke, or addiction. And the list goes on. The National Institutes of Health estimates that only about half of these people ever receive treatment. We can and we must do better. It is only through research that we can develop new effective treatments and I am committed to placing the DNI and the University of Rochester at the very forefront of these efforts.
May 7, 2015
A new $1.7 million grant will bring together a team of researchers to study – an ultimately thwart – the chain reaction that occurs in the body after cardiac arrest that can ultimately lead to brain damage and death.
While the biological sequence of events is triggered by cardiac arrest, the death and disability associated with this event is the result of a broader systemic injury caused the initial loss of blood flow and subsequent tissue inflammation once blood circulation is restored,said University of Rochester Medical Center neurologist Marc Halterman, M.D., Ph.D., the principal investigator of the study.
In fact, it is the cumulative effect of this systemic injury on the brain, and not the heart – that ultimately leads to mortality in the disorder.
April 27, 2015
Anolik Elected to American Society for Clinical Investigation
Dr. Jennifer Anolik with MSTP Director, Dr. Kerry O'Banion
Jennifer H. Anolik, M.D., Ph.D., associate professor of Medicine in the Division of Allergy/Immunology and Rheumatology, was named a member of the American Society for Clinical Investigation, one of the nation’s oldest and most respected medical honor societies. Anolik, who runs URMC’s Lupus Clinic and Program, was nominated for her work conducting translational and basic science research on lupus and rheumatoid arthritis. She joins 18 other Medical Center faculty members who have been inducted into the Society in the past. Anolik is a former URMC MSTP (M.D., '96) and Biochemistry (Ph.D., '94) student. During her time in the program, she conducted research with Robert Bambara, Ph.D. and Russell Hilf, Ph.D..
Anolik’s research focuses on the role of B cells in systemic autoimmune disease through synergistic and innovative approaches in translational immunology and animal models. It has fundamentally contributed to the understanding of how and why B cell targeted therapies can be efficacious in subsets of lupus and rheumatoid arthritis patients and established these therapies as a major advance in the field of immunologic disease. Her work has broad implications for other autoimmune diseases such as vasculitis and diabetes, as well immunologic diseases like malignancy and immune deficiency.
Under Anolik’s leadership, URMC was one of 11 research groups across the country recently chosen by the National Institutes of Health to join the NIH Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus Network, a partnership between the NIH, biopharmaceutical companies, advocacy organizations and academic scientists to more rapidly identify promising drug targets and develop new treatments for patients with these conditions. Anolik’s team was selected for this highly competitive award based on the novelty of their translational research proposal coupled with the unique collaboration between Orthopaedics and Rheumatology at URMC.
April 3, 2015
Researchers have identified a new genetic mutation at the heart of a severe and potentially deadly seizure disorder found in infants and young children. The finding, which was reported today in the American Journal of Human Genetics, may help scientists unravel the complex biological mechanism behind these diseases.
These findings allow us to open up what was, up to this point, a black box and more fully understand the biological pathways associated with these disorders and why some individuals do not respond to treatment,said Alex Paciorkowski, M.D., an assistant professor of Neurology at the University of Rochester Medical Center (URMC) and lead author of the study.
Once the mutation was identified, the researchers worked with neurobiologists in the lab of Marc Halterman, M.D., Ph.D. in the URMC Center for Neural Development and Disease, and were able to identify the downstream impact of the mutation, namely that it regulated another gene that has been associated with severe seizures called myocyte-specific enhancer factor 2C (MEF2C).
March 13, 2015
Irina Lerman Attends Endocrine Society's Annual Meeting & Expo
Current MD/PhD student, Irina Lerman attended the Endocrine Society's Annual Meeting & Expo in March 2015, held in San Diego. She was invited to compete in the Presidential Poster Competition for her first-authored top-scoring abstract, titled Neutrophil elastase potentiates human prostate cancer growth in mouse models. She is a first year graduate student in Dr. Steve Hammes' lab.
The Endocrine Society's Annual Meeting Steering Committee (AMSC) is an annual meeting incorporating current endocrine topics, speakers from around the world, and new and innovative formats that will incorporate basic research, clinical investigation, and clinical practice, with a goal of providing a venue for bridging the gaps in science and practice. The ENDO 2016 meeting in Boston, will celebrate the Centennial of the Endocrine Society.
February 23, 2015
SMD Ranks 12th Nationally in New Model to Evaluate Academic Physicians/Medical Schools
The School of Medicine and Dentistry placed 12th nationally in a new ranking designed to evaluate medical schools' production of academic physicians who advance medicine through basic, clinical, translational and implementation science research. The new model, detailed in Academic Medicine, the journal of the Association of American Medical Colleges, analyzes publications, grants, clinical trials and awards or honors for medical school graduates to arrive at a ranking that the authors argue is based on more relevant and objective criteria than those that dominate the current ranking systems.
The well-known yearly analysis performed by U.S. News & World Report has become the main tool to compare U.S. medical schools, but these rankings of research medical schools rely heavily on subjective and premedical student performance measures, including assessment scores from medical school deans, undergraduate grade point averages and school acceptance rates. Although U.S. News' research schools rankings incorporate total NIH funding and NIH dollars-per-faculty-member, these factors account for just 15 percent of the total score. (SMD was #34 in the 2015 U.S. News rankings; the 2016 rankings are due out next month.)
February 1, 2015
MSTP Announces 40th Anniversary Celebration!
The Medical Scientist Training Program (MSTP) is excited to announce a celebration of the 40th anniversary of the MSTP NIH training grant on Friday, October 9, 2015.
The keynote speaker will be an MSTP alumni from the Class of 1980: Edward Rubin, MD, PhD, Director, DOE Joint Genome Institute.
EddyRubin is an internationally-known geneticist and medical researcher at the Lawrence Berkeley National Laboratory in Berkeley, California, where he became head of the Genomic Sciences Division in 1998. In 2002 he assumed the directorship of the DOE Joint Genome Institute (JGI) to lead the JGI ’s involvement in the Human Genome Project (HGP).
For more information and schedule of events for the day, please visit the MSTP 40th Anniversary page.
February 1, 2015
MSTP Monthly Social Event: Curling
This past Saturday, January 31, the MSTP students visited the Rochester Curling Club for their monthly social event. Many of the current MSTP students attended the event including, Kyle Koster, Andrew Shubin, Andrew Cox, Aisha Seibert, Drew and Liz Scoles, Scott Friedland, and Kevin Makino.
Dating back to medieval Scotland, Curling is an Olympic sport (since 1998) in which players slide stones on a sheet of ice towards a target area which is segmented into four concentric circles. The sport has become increasingly popular with over 1.5 million curlers across the world.
Below are some photos and videos of the event. Please join us for our next social event!